Given the shared features between tumor cells and pulmonary endothelial cells in PAH patients, and the beneficial effects of the inhibitor treatment of Hsp110-STAT3 interaction in these diseases [27, 42], here we next tested the influence of Hsp110 on the regulation of the downstream STAT3 pathway in HPAECs. Here, STAT3 is linked to pulmonary arterial hypertension.